How does a BioPharma Cluster ascend the ranks to secure a Top 3 position? What are the key factors propelling the BioHealth Capital Region to achieve its ambitious goal of ranking 3rd by 2023? Join us in this episode of BioTalk, where our host Rich Bendis speaks with Alex Philippidis, Senior Business Editor at Genetic Engineering & Biotechnology News.
In this installment, Alex unveils the intricacies behind his latest Top 10 U.S. Biopharma Clusters, highlighting the impressive rise of the BioHealth Capital Region to its 3rd position. Learn about the origins of these rankings, the trends that have been identified for 2023, and the dynamic shifts within the BioPharma landscape on a regional scale.
Discover the journey of the Maryland/Virginia/Washington, DC, BioHealth Capital Region, which has realized its vision of securing a prominent seat among the top echelons of biopharma clusters. With an astounding portfolio of 52,899 patents, this achievement reflects the prolific presence of esteemed institutions such as Johns Hopkins, NIH, and the National Library of Medicine. Tune in to learn about the region's significant accomplishments, including its impressive 6,201 NIH funding awards amounting to $4.245 billion, and a sprawling 31.69 million square feet of cutting-edge lab space.
Join us as we unravel the insights that have propelled the BioHealth Capital Region to the forefront of BioPharma innovation and growth.
Dr. Gary Disbrow, Biomedical Advanced Research and Development Authority (BARDA) (EP.113)
Brian Castleberry, of the Maryland Department of Commerce & Robin Wiener of Get Real Health (EP.112)
Doug Falk, Vita Therapeutics (EP.111)
Dave Saunders, Galen Robotics (EP.110)
Mike Gill, Maryland Commerce Secretary (EP.109)
Ray Blanchard, Qiagen (EP.108)
Darryll J. Pines, University of Maryland (EP.107)
Ken Malone, Early Charm Ventures (EP.106)
Ron Kurz, Canon Virginia, Inc. (EP.105)
Marty Rosendale, Maryland Tech Council (EP.104)
Ron Piervincenzi, Ph.D., United States Pharmacopeia (EP.103)
Geoffrey Lynn, Vaccitech (EP.101)
Bill Enright, Vaccitech (EP.101)
Ellington West, Sonavi Labs (EP.100)
Amritha Jaishankar, PhD, Maryland Stem Cell Research Fund (MSCRF) (EP.99)
Mr. Hakdo Kim, President, Korea SMEs & Startups Agency KOSME)
Seth Toback, Novavax and Divya Chadha Manek, National Institute for Health Research (NIHR) (EP.97)
From the 7th Annual BioHealth Capital Region Forum - Dr. Tara Schwetz, Assistant Director for Biomedical Science Initiatives, White House Office of Science and Technology Policy (OSTP) (EP.96)
From the 7th Annual BioHealth Capital Region Forum - Dr. Anthony Fauci (EP.95)
Dr. Xavier Barril, Gain Therapeutics, and Hartaj Singh, Oppenheimer & Co. Inc. (EP.94)
Create your
podcast in
minutes
It is Free
The emPOWERed Half Hour
NABOR® TALKS
U.S Property Podcast
Aligned Money Show
The Ramsey Show
Planet Money